letrozole
Ligand Summary
Letrozole is a nonsteroidal competitive inhibitor of the aromatase enzyme system; it inhibits the conversion of androgens to estrogens. Used in treatment of hormonally responsive breast cancer (i.e., estrogen and/or progesterone receptor positive or receptor unknown)
UNII: 7LKK855W8I
PubChem: 3902
Guide to Pharmacology: 5209
ChEMBL: CHEMBL1444
DrugCentral: 1556
LyCHI: Y9KXTV3RGQQ5
Target Activities
37 Activities
Items per page:
1 – 10 of 37
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | ||||||
Ki | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||
IC50 | ||||||